Adenosine monophosphate-activated protein kinase in diabetic nephropathy
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, and its pathogenesis is complex and has not yet been fully elucidated. Abnormal glucose and lipid metabolism is key to understanding the pathogenesis of DN, which can develop in both type 1 and type 2 diabetes. A hallmark of...
Saved in:
Main Authors: | Yaeni Kim (Author), Cheol Whee Park (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diabetic conditions modulate the adenosine monophosphate-activated protein kinase of podocytes
by: Tae-Sun Ha, et al.
Published: (2014) -
Extracellular Superoxide Dismutase Attenuates Hepatic Oxidative Stress in Nonalcoholic Fatty Liver Disease through the Adenosine Monophosphate-Activated Protein Kinase Activation
by: Heechul Nam, et al.
Published: (2023) -
Adenosine monophosphate activated protein kinase contributes to skeletal muscle health through the control of mitochondrial function
by: Yan Yan, et al.
Published: (2022) -
Adenosine monophosphate‐activated protein kinase is elevated in human cachectic muscle and prevents cancer‐induced metabolic dysfunction in mice
by: Steffen H. Raun, et al.
Published: (2023) -
Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain
by: Peebles Katherine A, et al.
Published: (2011)